Literature DB >> 27086975

Oxidative injury in multiple sclerosis cerebellar grey matter.

Kevin Kemp1, Juliana Redondo2, Kelly Hares2, Claire Rice2, Neil Scolding2, Alastair Wilkins2.   

Abstract

Cerebellar dysfunction is a significant contributor to disability in multiple sclerosis (MS). Both white matter (WM) and grey matter (GM) injury occurs within MS cerebellum and, within GM, demyelination, inflammatory cell infiltration and neuronal injury contribute to on-going pathology. The precise nature of cerebellar GM injury is, however, unknown. Oxidative stress pathways with ultimate lipid peroxidation and cell membrane injury occur extensively in MS and the purpose of this study was to investigate these processes in MS cerebellar GM. Post-mortem human cerebellar GM from MS and control subjects was analysed immunohistochemically, followed by semi-quantitative analysis of markers of cellular injury, lipid peroxidation and anti-oxidant enzyme expression. We have shown evidence for reduction in myelin and neuronal markers in MS GM, coupled to an increase in expression of a microglial marker. We also show that the lipid peroxidation product 4-hydroxynonenal co-localises with myelin and its levels negatively correlate to myelin basic protein levels. Furthermore, superoxide dismutase (SOD1 and 2) enzymes, localised within cerebellar neurons, are up-regulated, yet the activation of subsequent enzymes responsible for the detoxification of hydrogen peroxide, catalase and glutathione peroxidase are relatively deficient. These studies provide evidence for oxidative injury in MS cerebellar GM and further help define disease mechanisms within the MS brain.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-oxidants; Cerebellum; Grey matter; Multiple sclerosis; Oxidative stress; Peroxidation

Mesh:

Substances:

Year:  2016        PMID: 27086975     DOI: 10.1016/j.brainres.2016.04.027

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis.

Authors:  Heather Y F Yong; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2021-11-03       Impact factor: 42.937

Review 2.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

3.  Impact of cisplatin administration on cerebellar cortical structure and locomotor activity of infantile and juvenile albino rats: the role of oxidative stress.

Authors:  Hanan E L Mokhtar; Mohey A E Hulail; Samar Mortada Mahmoud; Doaa Mohammed Yousef
Journal:  Anat Sci Int       Date:  2021-08-13       Impact factor: 1.741

Review 4.  NADPH oxidase in brain injury and neurodegenerative disorders.

Authors:  Merry W Ma; Jing Wang; Quanguang Zhang; Ruimin Wang; Krishnan M Dhandapani; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Neurodegener       Date:  2017-01-17       Impact factor: 14.195

Review 5.  Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Alastair Wilkins
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

Review 6.  Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.

Authors:  Cecilia Rajda; Dániel Pukoli; Zsuzsanna Bende; Zsófia Majláth; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

7.  Apelin-13: A Promising Biomarker for Multiple Sclerosis?

Authors:  Murat Alpua; Yakup Turkel; Ersel Dag; Ucler Kisa
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

8.  A Distinct Hibiscus sabdariffa Extract Prevents Iron Neurotoxicity, a Driver of Multiple Sclerosis Pathology.

Authors:  Manoj Kumar Mishra; Jianxiong Wang; Reza Mirzaei; Rigel Chan; Helvira Melo; Ping Zhang; Chang-Chun Ling; Aldo Bruccoleri; Lin Tang; V Wee Yong
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

9.  Antioxidant effect of grape seed extract corrects experimental autoimmune encephalomyelitis behavioral dysfunctions, demyelination, and glial activation.

Authors:  Maha Mabrouk; Mohamed El Ayed; Amélie Démosthènes; Youssef Aissouni; Ezzedine Aouani; Laurence Daulhac-Terrail; Meherzia Mokni; Mélina Bégou
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.